Inhibition of CXCR4 with the novel RCP168 peptide overcomes stroma-mediated chemoresistance in chronic and acute leukemias
Zhihong Zeng(The University of Texas MD Anderson Cancer Center), Marina Konopleva(Albert Einstein College of Medicine), Elihu H. Estey(University of Washington), Ismael Samudio(FPInnovations), Michael Andreeff(The University of Texas MD Anderson Cancer Center), Ziwei Huang(Stomatology Hospital), Jing An(University of California San Diego), Mark F. Munsell(The University of Texas MD Anderson Cancer Center)
Cited by 186
Related Papers
Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel
|Blood|2016|5.9k
Revised Recommendations of the International Working Group for Diagnosis, Standardization of Response Criteria, Treatment Outcomes, and Reporting Standards for Therapeutic Trials in Acute Myeloid Leukemia
|Journal of Clinical Oncology|2003|2.7k